Levetiracetam Oral Solution USP

2.1 Classification of the substance or mixture

This product is a mixture and is a pharmaceutical product. It is considered non- Hazardous according to the OSHA Hazard Communication Standard 2012 (29 CFR 1910.1200). Chemical family: Mixture

Hazard statements

Material is a liquid dosage form intended for human consumption. Solution is not considered hazardous taken as directed.

Additional information

Short term: The most common side effects include sleepiness, weakness, dizziness, and infection. In children additional side effects may include accidental injury, irritability and hostility. Long term: No data available Known Clinical Effects: Like other antiepileptic drugs, Levetiracetam may cause suicidal thoughts or actions in a very small number of people using it. EU Indication of danger: Not classified. 02 Emergency overview Seek medical attention in case of accidental exposure or overdose. The product is generally safe when used as prescribed. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential of exposure in your workplace.

Precautionary statements

General advice: Seek medical attention in case of accidental exposure or overdose. Eyes: Avoid contact with eyes. Skin Contact: Avoid skin contact. Inhalation: Not intended for inhalation. Ingestion: Generally safe at recommended doses. In case of overdose, seek medical attention immediately.

Storage

There are no special storage conditions for safety. For product integrity, store under conditions specified on the label.

Disposal

Dispose of in accordance with applicable laws and regulations.